IJMSC Author Spotlight shines a light on the people behind the research.
Possible future applications of optogenetics in MS therapy include the induction of oligodendrocyte proliferation, myelin synthesis, enhancing the repair of demyelinating processes, and modulating the severity of MS symptoms.
The management of walking impairment and fatigue may be appropriate for improving physical health-related quality of life among Black and White people with multiple sclerosis.